ColumbiaMagazine.com
Printed from:

Welcome to Columbia Magazine  
 

























 
KY pharmacist sentenced for conspiracy to distribute Oxycodone

'In his July 2017 guilty plea, (Michael) Ingram admitted that, while operating Hometown Pharmacy of Georgetown, he illegally distributed and dispensed oxycodone, by filling forged prescriptions from outside Kentucky.'
Click on headline for complete story

From U.S. Attorney's office
U.S. Department of Justice, Eastern District of Kentucky

LEXINGTON, Ky. - A Central Kentucky pharmacist, who owned and operated Hometown Pharmacy of Georgetown, has been sentenced to eight years in federal prison, followed by two years of home incarceration as a term of his supervised release, for Conspiracy to Distribute Oxycodone and Money Laundering.


Chief United States District Judge Karen K. Caldwell formally sentenced Michael Ingram, 37, of Cynthiana, KY, earlier today. Ingram must serve 85 percent of his sentence. Ingram has also forfeited in excess of $450,000 stemming from his criminal conduct.

In his July 2017 guilty plea, Ingram admitted that, while operating Hometown Pharmacy of Georgetown, he illegally distributed and dispensed oxycodone, by filling forged prescriptions from outside Kentucky. Ingram also admitted that his distribution and dispensation of these pills was outside the scope of pharmaceutical professional practice and was not for a legitimate medical purpose. Ingram further admitted that he used the proceeds of those illegal oxycodone sales to purchase the property now housing an additional business, Hometown Pharmacy of Cynthiana.

"We continue to see corrupt medical professionals choose profit over medical judgment and callously fuel an opioid epidemic that has decimated our state," said Carlton S. Shier, IV, Acting United States Attorney for the Eastern District of Kentucky. "This despicable conduct does enormous damage, both to individuals struggling with addiction and to our communities as a whole. Combatting this epidemic requires that we be clear: these egregious breaches of professional trust are criminal conduct that will be prosecuted."

Acting United States Attorney Shier; Mark McCormack, Special Agent in Charge, FDA Office of Criminal Investigations; Timothy J. Plancon, Special Agent in Charge, Drug Enforcement Administration; and Tracey D. Montano, Special Agent in Charge, IRS, Criminal Investigation, jointly announced the sentence. The case was prosecuted by Assistant United States Attorneys Andrew Smith and Cynthia Rieker


This story was posted on 2017-10-27 18:11:28
Printable: this page is now automatically formatted for printing.
Have comments or corrections for this story? Use our contact form and let us know.


To sponsor news and features on ColumbiaMagazine, please use our contact form.

 





















 
 
Quick Links to Popular Features


 

ColumbiaMagazine.com content is available as an RSS/XML feed for your RSS reader or other news aggregator.
Use the following link: http://www.columbiamagazine.com/columbiamagazinerss.php.

Contact us: Columbia Magazine and columbiamagazine.com are published by D'Zine, Ltd., PO Box 906, Columbia, KY 42728.
Phone: 270-250-2730 Fax: 270-751-0401


Please use our contact page, or send questions about technical issues with this site to webmaster@columbiamagazine.com. All logos and trademarks used on this site are property of their respective owners. All comments remain the property and responsibility of their posters, all articles and photos remain the property of their creators, and all the rest is copyright 1995-Present by Columbia! Magazine and D'Zine, Ltd. Privacy policy: use of this site requires no sharing of information. Voluntarily shared information may be published and made available to the public on this site and/or stored electronically. Anonymous submissions will be subject to additional verification. Cookies are not required to use our site. However, if you have cookies enabled in your web browser, some of our advertisers may use cookies for interest-based advertising across multiple domains. For more information about third-party advertising, visit the NAI web privacy site.